Bioxcel therapeutics to participate in two upcoming healthcare investor conferences

New haven, conn., may 04, 2021 (globe newswire) -- bioxcel therapeutics, inc. (“bioxcel” or the “company”) (nasdaq: btai), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that dr. vimal mehta, founder and chief executive officer of bioxcel, will participate in two upcoming virtual healthcare investor conferences.
BTAI Ratings Summary
BTAI Quant Ranking